Post job

Aptevo Therapeutics overview

Industry
Biotechnology
Revenue
Headquarters
Employees
58
Founded in
Website
Organization type
Public
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. They leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients.Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.
Based in Seattle, WA, Aptevo Therapeutics is a small health care company with only 58 employees and an annual revenue of $3.1M.

Aptevo Therapeutics's mission statement

To extend and meaningfully improve patients' lives.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Aptevo Therapeutics employee reviews

Be the first to review!

Do you work at Aptevo Therapeutics?

Help job seekers learn about working at Aptevo Therapeutics

On this page

Be the first to review Aptevo Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Aptevo Therapeutics?

The team at Aptevo Therapeutics

  • The founders of Aptevo Therapeutics is Marvin L. White.
  • The key people at Aptevo Therapeutics is Marvin L. White.
Key people
Marvin L. White

Aptevo Therapeutics rankings

Aptevo Therapeutics is ranked #15 on the Best Health Care companies to work for in Washington list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Rate Aptevo Therapeutics' commitment to diversity and inclusion.

Zippia waving zebra

Do you work at Aptevo Therapeutics?

Is Aptevo Therapeutics' workforce diverse and inclusive?

Aptevo Therapeutics financial performance

9.9
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Aptevo Therapeutics currently has 3.1M in revenue. Aptevo Therapeutics's most recent quarter produced 3.1m (q1'2022).

Aptevo Therapeutics annual revenue

$23M
$18M
$14M
$9M
$5M
$0
2016
2017
2018
2020
2021
2022

Are you an executive, HR leader, or brand manager at Aptevo Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Aptevo Therapeutics FAQs

Search for jobs

Zippia gives an in-depth look into the details of Aptevo Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aptevo Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Aptevo Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Aptevo Therapeutics. The data presented on this page does not represent the view of Aptevo Therapeutics and its employees or that of Zippia.

Aptevo Therapeutics may also be known as or be related to APTEVO THERAPEUTICS INC., Aptevo Therapeutics, Aptevo Therapeutics Inc, Aptevo Therapeutics Inc. and Aptevo Therapeutics, Inc.